Is Nanobiotix SA halal to invest in?

According to Musaffa's Shariah screening methodology, Nanobiotix SA (NANO.PA) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Nanobiotix SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nanobiotix SA using these criteria to determine its compliance status.

Can Muslims buy shares of Nanobiotix SA?

Muslim investors may consider investing in Nanobiotix SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Nanobiotix SA classified as HALAL?

Musaffa determines the Shariah status of Nanobiotix SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Nanobiotix SA updated?

The Shariah compliance status of Nanobiotix SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Nanobiotix SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Nanobiotix SA?

You can check the latest Shariah compliance status of Nanobiotix SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Nanobiotix SA NANO.PA

€44.26 €1.62 (3.53%) 1D

Last Updated: May 15, 12:00 AM·XPAR

NANO.PA Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: April 16, 2026

Report Source: 2025 Annual Report

Nanobiotix SA. Stock Analysis NANO.PA

France Health Care Small Cap Report: 2025 Annual

Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. The company employs 97 full-time employees The company went IPO on 2012-10-29. The firm designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. The company develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The firm's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.

Key Statistics of Nanobiotix SA (NANO.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€42.66€46.50

Today's Open

€45.88

Volume

59.23K

P/E Ratio (TTM)

52 Week Range

€3.28€47.60

Market Cap

1.28B

Avg. Volume

146.36K

Dividend Yield

Financial Metrics & Statements of Nanobiotix SA (NANO.PA)

FAQ's for Nanobiotix SA (NANO.PA)

According to Musaffa’s Shariah screening methodology, Nanobiotix SA (NANO.PA) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.